Global Central Lab Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Central Lab Market is presumed to reach the market size of nearly USD 7.2 BN by 2030 from USD 4.04 BN in 2022 with a CAGR of 7.5% under the study period 2023 - 2030.

Central labs are typically contracted by pharmaceutical companies, contract research organizations (CROs), or academic institutions to conduct laboratory testing for multiple clinical trial sites spread across different locations. The purpose of using a central lab is to ensure standardized and consistent analysis of samples, minimizing variations that could occur if each site performed its own testing.

MARKET DYNAMICS:

The pharmaceutical industry is investing heavily in R&D to develop new drugs and treatments, leading to an increased demand for laboratory services. Clinical trials are critical for the drug development process. Central labs can provide a range of services to support clinical trials, such as sample collection, processing, and analysis. Moreover, personalized medicine requires a more sophisticated approach to laboratory testing, which central labs can provide. Central labs are adopting automation and artificial intelligence to improve efficiency and accuracy. This is leading to increased demand for their services. However, the healthcare industry is subject to stringent regulations, which can make central labs operation difficult and costly. Also, hospitals and clinics are increasingly offering laboratory services which may affect the market negatively.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of central lab. The growth and trends of central lab industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the central lab market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Services

Genetic Services
Biomarker Services
Microbiology Services
Anatomic Pathology/Histology
Specimen Management & Storage
Special Chemistry Services
Others

By End-Use

Pharmaceutical Companies
Biotechnology Companies
Academic & Research Institutes

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Central Lab market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the central lab market include ACM Global Laboratories; Labconnect; Cerba Research; Eurofins Scientific; Medicover Integrated Clinical Services; Versiti; A.P. Møller Holding A/S; Ampersand Capital Partners; Lambda Therapeutic Research Ltd; Cirion Biopharma Research Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

Product Code: VMR112111307

1 . PREFACE

1.1. Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CENTRAL LAB - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Services
- 3.7.2 Market Attractiveness Analysis By End-use
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CENTRAL LAB MARKET ANALYSIS BY SERVICES

5.1 Overview by Services
5.2 Historical and Forecast Data
5.3 Analysis by Services
5.4 Genetic Services Historic and Forecast Sales by Regions
5.5 Biomarker Services Historic and Forecast Sales by Regions
5.6 Microbiology Services Historic and Forecast Sales by Regions
5.7 Anatomic Pathology/Histology Historic and Forecast Sales by Regions
5.8 Specimen Management & Storage Historic and Forecast Sales by Regions
5.9 Special Chemistry Services Historic and Forecast Sales by Regions
5.10. Others Historic and Forecast Sales by Regions

6 . GLOBAL CENTRAL LAB MARKET ANALYSIS BY END-USE

6.1 Overview by End-use
6.2 Historical and Forecast Data
6.3 Analysis by End-use
6.4 Pharmaceutical Companies Historic and Forecast Sales by Regions
6.5 Biotechnology Companies Historic and Forecast Sales by Regions
6.6 Academic & Research Institutes Historic and Forecast Sales by Regions

7 . GLOBAL CENTRAL LAB MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Data Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Data Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Data Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Data Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Data Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE CENTRAL LAB COMPANIES

8.1. Central Lab Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF CENTRAL LAB INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. ACM Global Laboratories
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. Labconnect
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. Cerba Research
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. Eurofins Scientific
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. Medicover Integrated Clinical Services
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. Versiti
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments
9.9. A.P. Møller Holding A/S
- 9.9.1. Company Overview
- 9.9.2. Company Revenue
- 9.9.3. Products
- 9.9.4. Recent Developments
9.10. Ampersand Capital Partners
- 9.10.1. Company Overview
- 9.10.2. Company Revenue
- 9.10.3. Products
- 9.10.4. Recent Developments
9.11. Lambda Therapeutic Research Ltd
- 9.11.1. Company Overview
- 9.11.2. Company Revenue
- 9.11.3. Products
- 9.11.4. Recent Developments
9.12. Cirion Biopharma Research Inc.
- 9.12.1. Company Overview
- 9.12.2. Company Revenue
- 9.12.3. Products
- 9.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies